Judge Gavel Court

Labcorp agrees to pay over $2 million to settle False Claims Act allegations related to overbillings on Department of Defense contracts

Posted on by Chris Montcalmo

BALTIMORE, MD—Laboratory Corporation of America has agreed to pay the U.S. $2,100,000 to resolve allegations that it violated the federal False Claims Act by overbilling the Department of Defense for genetic tests performed by GeneDx, LLC, a third-party reference laboratory used by Labcorp to perform genetic tests for military members. The civil settlement was announced by United States Attorney for […]

Continue Reading
Judge Gavel Court

Maryland hospital to pay more than $2 million to resolve False Claims Act case regarding Medicare, Medicaid

Posted on by Chris Montcalmo

BALTIMORE, MD—A Maryland health care facility will pay more than $2 million to resolve a False Claims Act case regarding the billing of services to Medicare and Medicaid. Luminis Health Doctors Community Medical Center, Inc., (“DCMC”), and Diagnostic Imaging Associates, LLC (“DIA”), both located in Lanham, have agreed to pay the United States $2,002,052.17 to resolve allegations that they violated […]

Continue Reading
Gavel Scales Justice Crime

Maryland U.S. Attorney’s Office collects over $26 million in civil, criminal actions for U.S. taxpayers in FY 2021

Posted on by Chris Montcalmo

BALTIMORE, MD—U.S. Attorney Erek L. Barron this week announced that financial collections in criminal and civil actions in Fiscal Year (FY) 2021 in the District of Maryland reached $26,206,937.09. The U.S. Department of Justice keeps statistics on a fiscal year basis, closing the books each September 30th. “Thanks to the hard work and dedication of employees of the U.S. Attorney’s […]

Continue Reading
Judge Gavel Court

St. Jude Medical agrees to pay $27 million for allegedly selling defective heart devices

Posted on by Chris Montcalmo

BALTIMORE, MD—St. Jude Medical, Inc. has agreed to pay $27 million to settle allegations under the False Claims Act that, between November 2014 and October 2016, it knowingly sold defective heart devices to health care facilities that, in turn, implanted the devices into patients insured by federal healthcare programs. St. Jude was acquired by Abbott Laboratories in January 2017. The […]

Continue Reading